At a glance
This program funds planning, development, and pilot studies for lupus research that can produce preliminary data and show feasibility for a future interventional study. Applicants must be eligible U.S. Department of War organizations and independent investigators at eligible organizations; applications must include at least one lupus consumer advocate. The award is a grant with a maximum of $250,000 in total costs over up to 2 years, and cost sharing is not required. The announcement allows phase 0/1 clinical trials and other clinical research, but not phase 2/3 clinical trials or animal studies. Approximately two awards are expected, and the research must address at least one FY26 focus area for improving outcomes through health care delivery or interventions for people living with lupus.
What it funds
Official description from grants.gov
Summary: This funding mechanism supports planning and development activities and pilot studies that will generate preliminary data and demonstrate feasibility for achieving the aims of a future interventional study. Successful studies may be submitted to a future Lupus Research Program (LRP) Transformative Vision Award (TVA), or equivalent, for funding consideration (See Funding Opportunity Number HT942526LRPTVA for additional information). Research must address at least one of the fiscal year 2026 (FY26) LRP Transformative Vision Development Award (TVDA) focus areas. This funding mechanism allows for phase 0/1 clinical trials, if appropriate. The mechanism does not allow for phase 2/3 clinical trials or animal studies. Distinctive Features: • Preliminary data are permitted but not required. • Applications must include at least one lupus consumer advocate as a member of the research team. • An individual may be named as Principal Investigator (PI) on only one application per LRP award mechanism (Idea Award, Impact Award, TVDA, TVA), for a maximum of four applications to the FY26 LRP.
Who can apply
- Unrestricted